Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 5, 2017, Pages 609-620

  Reyes, Luis F ^a,b   Restrepo, Marcos I ^a,b   Hinojosa, Cecilia A ^a,b   Soni, Nilam J ^a,b   Anzueto, Antonio ^a,b   Babu, Bettina L ^a,b   Gonzalez Juarbe, Norberto ^c   Rodriguez, Alejandro H ^d,e   Jimenez, Alejandro ^f   Chalmers, James D ^g   Aliberti, Stefano ^h,i,j   Sibila, Oriol ^k   Winter, Vicki T ^l   Coalson, Jacqueline J ^l   Giavedoni, Luis D ^m   Dela Cruz, Charles S ⁿ   Waterer, Grant W ^o   Witzenrath, Martin ^p,q   Suttorp, Norbert ^p,q   Dube, Peter H ^r   Orihuela, Carlos J ^c   more..

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

^g UNIVERSITY OF DUNDEE   (United Kingdom)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ Cardio thoracic Unit and Adult Cystic Fibrosis Centre   (Italy)

^j FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^k UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^l University of Texas Health Science Center   (United States)

^m SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

ⁿ YALE UNIVERSITY   (United States)

^o UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^p Department of Infectious Diseases and Pulmonary Medicine ^*  (United States)

^q CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^r UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

more..

Author keywords

Cardiovascular complications; Community acquired pneumonia; Pneumococcal pneumonia; Streptococcus pneumoniae

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; EOSIN; FATTY ACID BINDING PROTEIN; HEMATOXYLIN; TROPONIN T; ANTIINFECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; APOPTOSIS; ARTICLE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CARDIOTOXICITY; CELL DEATH; CONTROLLED STUDY; CONVALESCENCE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART INJURY; HEART TISSUE; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; NECROPTOSIS; NONHUMAN; PRIMATE MODEL; PRIORITY JOURNAL; SCAR FORMATION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BABOON; BLOOD; COMPLICATION; DISEASE MODEL; FEMALE; HEART; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PNEUMONIA, PNEUMOCOCCAL; WESTERN BLOTTING;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOTTING, WESTERN; CARDIOTOXICITY; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATTY ACID-BINDING PROTEINS; FEMALE; HEART; MALE; MYOCARDIUM; PAPIO; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; TROPONIN T;

EID: 85028686769     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201701-0104OC     Document Type: Article

References (51)

1. Wunderink RG, Waterer GW. Community-acquired pneumonia. N Engl J Med 2014;370:1863.
2. Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet 2015;386:1097-1108.
3. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and causespecific mortality for 249 causes of death, 1980-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388:1459-1544.
4. Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial. JAMA 2015;313:677-686.
5. Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med 2014;371:1619-1628.
6. Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang CC, Newman A, Loehr L, Folsom AR, Elkind MS, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 2015;313:264-274.
7. Corrales-Medina VF, Taljaard M, Yende S, Kronmal R, Dwivedi G, Newman AB, Elkind MS, Lyles MF, Chirinos JA. Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults. Am Heart J 2015;170:306-312.
8. Corrales-Medina VF, TaljaardM, Fine MJ, Dwivedi G, Perry JJ, Musher DM, Chirinos JA. Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia. Mayo Clin Proc 2014;89:60-68.
9. Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet 2013;381: 496-505.
10. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 2012;125:773-781.
11. Viasus D, Garcia-Vidal C, Manresa F, Dorca J, Gudiol F, Carratalà J. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. J Infect 2013;66:27-33.
12. Musher DM, Rueda AM, Kaka AS, Mapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007;45:158-165.
13. Corrales-Medina VF, Suh KN, Rose G, Chirinos JA, Doucette S, Cameron DW, Fergusson DA. Cardiac complications in patients with community-acquired pneumonia: A systematic review and meta-analysis of observational studies. PLoS Med 2011;8:e1001048.
14. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, et al.; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015;373:415-427.
15. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI; GLIMP investigators. Global Initiative for Methicillinresistant Staphylococcus aureus Pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis 2016;16:1364-1376.
16. Rae N, Finch S, Chalmers JD. Cardiovascular disease as a complication of community-acquired pneumonia. Curr Opin Pulm Med 2016;22:212-218.
17. Brown AO, Mann B, Gao G, Hankins JS, Humann J, Giardina J, Faverio P, Restrepo MI, Halade GV, Mortensen EM, et al. Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function. PLoS Pathog 2014;10:e1004383.
18. Gilley RP, González-Juarbe N, Shenoy AT, Reyes LF, Dube PH, Restrepo MI, Orihuela CJ. Infiltrated macrophages die of pneumolysin-mediated necroptosis following pneumococcal myocardial invasion. Infect Immun 2016;84:1457-1469.
19. Alhamdi Y, Neill DR, Abrams ST, Malak HA, Yahya R, Barrett-Jolley R, Wang G, Kadioglu A, Toh CH. Circulating pneumolysin is a potent inducer of cardiac injury during pneumococcal infection. PLoS Pathog 2015;11:e1004836.
20. Fillon S, Soulis K, Rajasekaran S, Benedict-Hamilton H, Radin JN, Orihuela CJ, El Kasmi KC, Murti G, Kaushal D, Gaber MW, et al. Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J Immunol 2006;177:6182-6191.
21. Feldman C, Anderson R. Recent advances in our understanding of Streptococcus pneumoniae infection. F1000Prime Rep 2014;6:82.
22. Brown AO, Millett ER, Quint JK, Orihuela CJ. Cardiotoxicity during invasive pneumococcal disease. Am J Respir Crit Care Med 2015; 191:739-745.
23. González-Juarbe N, Gilley RP, Hinojosa CA, Bradley KM, Kamei A, Gao G, Dube PH, Bergman MA, Orihuela CJ. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog 2015;11:e1005337.
24. Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv F, Liu Y, Zheng W, Shang H, Zhang J, et al. CaMKII is a RIP3 substrate mediating ischemia-and oxidative stress-induced myocardial necroptosis. Nat Med 2016;22:175-182.
25. Linkermann A, Hackl MJ, Kunzendorf U, Walczak H, Krautwald S, Jevnikar AM. Necroptosis in immunity and ischemia-reperfusion injury. Am J Transplant 2013;13:2797-2804.
26. Linkermann A, Bräsen JH, Darding M, Jin MK, Sanz AB, Heller JO, De Zen F, Weinlich R, Ortiz A, Walczak H, et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci USA 2013;110:12024-12029.
27. Restrepo MI, Reyes LF, Anzueto A. Complication of communityacquired pneumonia (including cardiac complications). Semin Respir Crit Care Med 2016;37:897-904.
28. Reyes LF, Restrepo MI, Hinojosa CA, Soni NJ, Shenoy AT, Gilley RP, Gonzalez-Juarbe N, Noda JR, Winter VT, de la Garza MA, et al. A non-human primate model of severe pneumococcal pneumonia. PLoS One 2016;11:e0166092.
29. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 2001;293:498-506.
30. Giavedoni LD. Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using Luminex technology. J Immunol Methods 2005;301:89-101.
31. Bujak M, Frangogiannis NG. The role of TGF-b signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007;74:184-195.
32. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, et al. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 2001;35:376-385.
33. Goldsmith EC, Bradshaw AD, Spinale FG. Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression. Am J Physiol Cell Physiol 2013;304:C393-C402.
34. Kim JH, Park MY, Kim CN, Kim KH, Kang HB, Kim KD, Kim JW. Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1a in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features. Oncol Rep 2012;28:1701-1708.
35. Restrepo MI, Mortensen EM, Rello J, Brody J, Anzueto A. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest 2010;137: 552-557.
36. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, et al.; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Nephrol Dial Transplant 2007;44(Suppl 2): S27-S72.
37. Rudiger A, Singer M. The heart in sepsis: from basic mechanisms to clinical management. Curr Vasc Pharmacol 2013;11:187-195.
38. Zaky A, Gill EA, Lin CP, Paul CP, Bendjelid K, Treggiari MM. Characteristics of sepsis-induced cardiac dysfunction using speckle-tracking echocardiography: A feasibility study. Anaesth Intensive Care 2016;44:65-76.
39. Ammann P, Fehr T, Minder EI, Günter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001;27:965-969.
40. Altmann DR, Korte W, MaederMT, Fehr T, Haager P, Rickli H, Kleger GR, Rodriguez R, Ammann P. Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS One 2010;5:e9017.
41. Vestjens SMT, Spoorenberg SMC, Rijkers GT, Grutters JC, Ten Berg JM, Noordzij PG, Van de Garde EMW, Bos WJW; Ovidius Study Group. High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia. Respirology 2017;22:1000-1006.
42. Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M, Criollo A, Nemchenko A, Hill JA, Lavandero S. Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 2011;2:e244.
43. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, Kitsis RN. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemiareperfusion in vivo. Am J Physiol Heart Circ Physiol 2003;284: H456-H463.
44. Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature 2015;517:311-320.
45. Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol 2015;16:689-697.
46. Yin B, Xu Y, Wei RL, He F, Luo BY, Wang JY. Inhibition of receptorinteracting protein 3 upregulation and nuclear translocation involved in necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury. Brain Res 2015;1609:63-71.
47. Gonzalez-Juarbe N, Gilley R, Riegler AN, Bradley KM, Reyes LF, Shenoy AT, Brissac T, Herrera AI, Dube PH, Restrepo MI, et al. Necroptosis: A major cell death mechanism induced by pore-forming toxins during bacterial pneumonia. Presented at the Institutional Research and Academic Career Development Award Annual Meeting. June 5, 2017, Birmingham, AL. Abstract E69, p. 23
48. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: The renaissance cell. Circ Res 2009;105:1164-1176.
49. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002;91:988-998.
50. Aliberti S, Ramirez JA. Cardiac diseases complicating communityacquired pneumonia. Curr Opin Infect Dis 2014;27:295-301.
51. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association for Clinical Chemistry. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;64:e139-e228.